Magnetic resonance imaging and diffusion-weighted imaging in methylmalonic acidemia

Acta Radiologica

Volumn 46, Issue 1, 2005, Pages 101-103

  Yesildag A ^a,b   Ayata, A ^a   Baykal, B ^a   Koroglu, M ^a   Yildiz, H ^a   Oral, B ^a   Oktem, F ^a   Oyar, O ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Diffusion weighted imaging; Magnetic resonance imaging; Methylmalonic acidemia

Indexed keywords

AMINO ACIDS; BRAIN; METABOLISM; NEUROLOGY; PATIENT TREATMENT;

DIFFUSION-WEIGHTED IMAGING; METHYLMALONIC ACIDEMIA;

MAGNETIC RESONANCE IMAGING;

METHYLMALONIC ACID;

ACIDOSIS; ARTICLE; BLOOD; CASE REPORT; DIFFUSION WEIGHTED IMAGING; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; GLOBUS PALLIDUS; HUMAN; INFANT; MALE; PATHOLOGY;

ACIDOSIS; AMINO ACID METABOLISM, INBORN ERRORS; DIFFUSION MAGNETIC RESONANCE IMAGING; GLOBUS PALLIDUS; HUMANS; INFANT; MALE; METHYLMALONIC ACID;

EID: 18744415975     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850510020888     Document Type: Article

References (14)

1. Brismar J, Ozand PT. CT and MR of the brain in disorders of the propionate and methylmalonate metabolism. Am J Neuroradiol 1994;15:1459-73.
2. Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 1999;212:333-9.
3. Burlina AP, Manara R, Calderone M, Catuogno S, Burlina AB. Diffusion weighted imaging in the assessment of the neurological damage in patient with methylmalonic aciduri. J Inherit Metab Dis 2003;26:417-22.
4. Engelter ST, Provenzale JM, Petrella JR, Alberts MJ, DeLong DM, MacFall JR. Use of exponential diffusion imaging to determine the age of ischemic infarcts. Neuroimaging 2001;11:141-7.
5. Michel SJ, Given CA 2nd, Robertson WC Jr. Imaging of the brain, including diffusion-weighted imaging in methylmalonic acidemia. Pediatr Radiol 2004;34: 580-2.
6. Nicolaides P, Leonard J, Surtees R. Neurological outcome of methylmalonic acidaemia. Arch Dis Child 1998;78:508-12.
7. Sener RN. Metachromatic leukodystrophy. Diffusion MR imaging and proton MR spectroscopy. Acta Radiol 2003;44:440-3.
8. Server A, Hovda KE, Nakstad PH, Jacobsen D, Dullerud R, Haakonsen M. Conventional and diffusion-weighted MRI in the evaluation of methanol poisoning. Acta Radiol 2003;44:691-5.
9. Singhal AB, Topcuoglu MA, Koroshetz WJ. Diffusion MRI in three types of anoxic encephalopathy. J Neurol Sci 2002;196:37-40.
10. Takeuchi M, Harada M, Matsuzaki K, Hisaoka S, Nishitani H, Mori K. Magnetic resonance imaging and spectroscopy in a patient with treated methylmalonic acidemia. J Comput Assit Tomogr 2003;27: 547-51.
11. Teksam M, Casey SO, Michel E, Liu H, Truwit CL. Diffusion-weighted MR imaging findings in carbon monoxide poisoning. Neuroradiology 2002;44:109-13.
12. Trinh BC, Melhem ER, Barker PB. Multi-slice proton MR spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. Am J Neuroradiol 2001;22: 831-3.
13. van der Meer SB, Poggi F, Spada M, et al. Clinical outcome of long-term management of patients with vitamin B12 unresponsive methylmalonic acidemia. J Pediatr 1994;125:903-8.
14. Wajner M, Coelho JC. Neurological dysfunction in methylmalonic acidemia is probably related to the inhibitory effect of methylmalonate on brain energy production. J Inherit Metab Dis 1997;20:761-8.